Sunday, December 1, 2019

Sun Pharma to defend antitrust claims over delayed entry of 3 generic drugs in US

Sun Pharma to defend antitrust claims over delayed entry of 3 generic drugs in US Sun Pharma said the litigation had already been disclosed in the company#39;s FY19 annual report.

from Moneycontrol Business News https://ift.tt/2ODfudW

No comments:

Post a Comment

Bitcoin won over Wall Street and now it’s paying the price

Bitcoin's integration with American finance brought stability but created a new weakness. Institutional investors expected Bitcoin to he...